In a First for the Industry, SharpLink Buys Almost 75,000 Ethereum. Here’s Why Investors Should Take Note. Companies can earn yield by staking their
Author: techrossm
Stock Market Today: Dow Futures Fall; Trade Talks, Earnings in Spotlight
Trump’s tariffs and recent trade deals continue to affect global markets. Follow along for live updates on the Dow, S&P 500 and Nasdaq.
Billionaire Chase Coleman Sold 94% of His Fund’s Stake in Uber and Is Loading Up on a Skyrocketing Stock Whose Addressable Market Can 11X by 2032
Tiger Global Management’s billionaire chief is piling into a market-leading company whose stock has catapulted close to 1,000% over the trailing decade.
Sensex tumbles over 500 points. Why stock market is down today
The S&P BSE Sensex dropped 537.11 points to 82,189.53 by 12:37 pm, while the NSE Nifty50 fell 150.10 points to 25,069.80. All broader market
Small-cap stock DEV IT shows resilience despite selling pressure in Indian stock market
The small-cap stock opened at ₹117.36 in early morning session on Thursday, as compared to previous close of ₹116.07 on Wednesday. At 10:40 am,
In 27 Years of Investing, I’ve Never Witnessed a More Overvalued Megacap Stock
For more than three decades, investors have been privy to no shortage of next-big-thing trends and game-changing innovations. Pie-in-the-sky addressable markets assigned to new
What you need to know about investing during uncertain times
By Robert Van Alphen With concerns about renewed tariff wars between the U.S. and key global trading partners, many Canadians—especially in Penticton—are wondering how
Why investing matters: How to build your wealth and beat inflation
In this first chapter of This is Money’s new investing guides series, Simon Lambert explains why investing over the long-term pays off.
Tharimmune Announces Pricing of $1.74 Million Registered Direct Public Offering of Common Stock and Warrants
RED BANK, NJ / ACCESS Newswire / July 23, 2025 / Tharimmune, Inc. (the “Company” and “Tharimmune”) (Nasdaq Capital Market:THAR), a clinical-stage biotechnology company
Lightyear app launches AI features to make investing less ‘expensive, clunky and exclusive’
Lightyear, which recently passed $1billion in assets under management, said its new AI tools will help to make UK retail investing ‘affordable, simple, and